Akinchan Bhardwaj: Will Plaque Imaging Eventually Reshape Preventive Cardiology Workflows?
Akinchan Bhardwaj, Consultant Interventional Cardiologist at Kauvery Hospital, shared a post on LinkedIn:
“For 50 years, cardiology has estimated risk.
Now we can actually ‘see’ disease.
Traditional risk scores, Framingham, ASCVD estimate the probability of coronary disease.
But they don’t show the artery.
Coronary CT angiography (CCTA) changes that.
In addition to measuring calcium, It reveals:
- total plaque burden
- plaque composition
- high-risk features
- early non-calcified disease
Studies like SCOT-HEART and large registries such as CONFIRM suggest that visualizing plaque can change management and potentially outcomes.
This raises an uncomfortable question for prevention:
If we can directly see coronary atherosclerosis, how long will probability-based risk models remain the center of decision-making?
Risk scores estimate likelihood. Imaging reveals biology.
The future of preventive cardiology may lie in combining both genetics, biomarkers, AI and direct plaque visualization to identify disease before events occur.
Prevention has always been about acting earlier and CCTA may allow us to act earlier with evidence, not estimates.
Will plaque imaging eventually reshape preventive cardiology workflows?
Curious how experts view this, Dr. Pradeep Natarajan if you have thoughts on where plaque imaging fits into preventive workflows.”

Other posts featuring Akinchan Bhardwaj on Hemostasis Today.
-
Oct 30, 2026, 05:18Flora Peyvandi: Molecular and Lab Markers Linked to Bleeding Severity in Factor VII Deficiency
-
Oct 30, 2026, 05:11Rana Al-Hrout: Exploring Approach to Macrocytic Anemia
-
Oct 30, 2026, 04:22Francisco Chacón-Lozsán: Acute Pulmonary Embolism in 2026 – Blood Pressure Is Not the Same as Perfusion
-
Oct 30, 2026, 04:15Samin Mohsenian: Launching the PRO-RBDD-FX Registry for Rare Coagulation Factor X Deficiency
-
Oct 30, 2026, 03:59Emil List Larsen: Identifying SERPINC1 Variants and Limitations of Routine Antithrombin Testing
-
Oct 30, 2026, 02:43D Chandra: Reduce the Apixaban Dose for a Patient with VTE and a Creatinine Clearance of 25?
-
Oct 30, 2026, 02:38Spencer Dorn: Why AI Decision Support Must Integrate Local Clinical Context
-
Oct 30, 2026, 02:33Jens Eschen: Randomized Controlled Trial on Acute Aortic Dissection Anticoagulation Strategies
-
Oct 30, 2026, 02:23Mavis Agnes Kisakye: Landmark Study Paves the Way for Standardized Bleeding Disorder Guidelines in Uganda